Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Light
Dark
System
Revvity | PKI - Aset Lancar
Keuangan
Harga Saham
USD 151.59
Aktiva
USD 11.49B
Kas Dan Setara
USD 592.8M
Biaya Penjualan
USD 310.32M
Aset Lancar
USD 1.86B
Kewajiban Lancar
USD 701.48M
UTANG
USD 2.63B
Dividen - Hasil
0.19
EBIT
USD 124.63M
EBITDA
USD 227.55M
Karyawan
11K
Eps Laba Per Saham
USD 1.37
Modal Dan Cadangan
USD 7.23B
Laba Kotor Pada Penjualan
USD 418.58M
Beban Bunga Utang
USD 20.81M
Pendapatan Bunga
USD -22.99M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 19.08B
Batas Pemasukan
USD 62.3M
Biaya Operasional
USD 604.27M
Laba Operasional
USD 124.63M
Modal Saham Biasa
USD 111.59M
Pe Harga Untuk Laba
56.86
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729M
Beban Penjualan Dan Administrasi
USD 275.33M
Saham
USD 388.85M
Kreditur Perdagangan
USD 163.27M
Debitur Perdagangan
USD 687.33M
Aset Lancar
Perubahan
Tanggal
Agilent
USD 4.69B
70M
2026-06
Align Technology
USD 2.73B
63.03M
2026-09
Bio Techne
USD 824.83M
80.43M
2026-09
Bio-Rad Laboratories
USD 3.08B
58.1M
2026-09
Bruker
USD 2.16B
67.9M
2026-09
Celltrion
KRW 493.66B
12.09B
2026-06
Charles River Laboratories
USD 1.54B
5.92M
2026-09
Cspc Pharmaceutical
CNY 22.25B
359.48M
2025-12
Danaher
USD 14.79B
1.41B
2026-09
Dentsply International
USD 1.98B
50M
2026-09
Deva Holding AS
TRY 9.13B
1.61B
2023-09
Dianthus Therapeutics
USD 856.04M
41.5M
2026-09
Divis Laboratories Ltd
INR 124.39B
13.43B
2026-09
Edwards Lifesciences
USD 7.25B
428.6M
2026-09
Illumina
USD 3.04B
201M
2026-09
Intuitive Surgical
USD 10.65B
1.68B
2026-09
IQVIA Holdings
USD 6.45B
225M
2026-09
Kangmei Pharma
CNY 6.66B
143.43M
2026-06
Knight Therapeutics
CAD 394.84M
5.86M
2025-12
Laboratorios Farma
EUR 509.33M
128.63M
2023-12
Laboratory Of America
USD 3.97B
151.3M
2026-09
Malin Corporation
EUR 62.6M
26.7M
2024-12
Medical Developments International
AUD 33.75M
1.79M
2025-12
Mesa Laboratories
USD 105.63M
8.2M
2025-12
Mettler Toledo International
USD 1.38B
28.79M
2026-09
Myriad Genetics
USD 289M
23.8M
2026-06
Neuren Pharmaceuticals
AUD 332.23M
11.98M
2025-12
OraSure Technologies
USD 222.94M
17.84M
2026-06
Organigram Holdings
CAD 280.09M
30M
2026-06
Ovoca Bio
EUR 2.07M
510K
2025-12
Pacific Biosciences Of California
USD 307.85M
30.78M
2026-09
Pharma Mar
EUR 295.56M
14.62M
2026-09
Qiagen NV
USD 1.66B
116.37M
2026-06
Quest Diagnostics
USD 3.12B
273M
2026-09
Quidel
USD 1.45B
69.4M
2026-09
Repligen
USD 1.24B
41.43M
2026-09
Revvity
USD 1.86B
436.33M
2026-09
Sartorius
EUR 1.65B
8.4M
2026-09
Sino Biopharmaceutical
CNY 33.82B
9.13B
2025-06
Thermo Fisher Scientific
USD 25.62B
2.25B
2026-09
Tilray
USD 729.32M
28.18M
2025-09
Waters
USD 3.9B
186M
2026-06
Zealand Pharma A/S
15.02B
652.12M
2026-03
Zz Pientze Pharmaceu
CNY 13.48B
2.32B
2026-09
×